Wednesday 14 May, 2008

Aurbindo got MCC approval

Hyderabad based Aurobindo Pharma has received approvals from the Medicines Control Council (MCC) to manufacture and market nine products in South Africa. These products are estimated to have a generic market size of ZAR 165 million in the local market The following products received approval from MCC:
1) Auro-Lisinopril Co (CVS)
2) Auro-Amlodipine (CVS)
3) Auro-Finasterid (BPH)
4) Zinoxime (anti-infective)
5) Zolid (CNS)
6) Yomax (anti-infective)
7) Lazivir (ARV)
8) Lisinozide (CVS)
9) Profina (BPH)

Posted by ADKS at 12:45 pm

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker